Matches in SemOpenAlex for { <https://semopenalex.org/work/W1589248370> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W1589248370 endingPage "5" @default.
- W1589248370 startingPage "201" @default.
- W1589248370 abstract "The use of preoperative imaging in patients with hyperparathyroidism remains controversial. The aim of this study is to assess the usefulness of the double-phase 99mTc-sestamibi scintigraphy in the diagnosis of abnormal parathyroid glands in patients with primary hyperparathyroidism.We studied 60 patients presenting with primary hyperparathyroidism who were referred to surgery; four of them had been unsuccessfully operated. 99mTc-sestamibi scintigraphy were performed in all patients previously to surgery. Scintigraphic technique: planar imaging of the neck and thorax was done in the anterior view at 15 and 150 min postinjection of 740 MBq (20 mCi) of 99mTc-sestamibi.Surgery found 57 adenomas (2.59 [SD, 5.84] g; range 0.160-40), 6 hyperplastic glands (0.34 [SD, 0.26] g) and one carcinoma 8.2 g. The 99mTc-sestamibi was able to localize correctly 60 out of 64 lesions (55/57 adenomas, 4/6 hyperplastic glands and 1/1 carcinoma) (global sensitivity of 94%, adenomas sensitivity of 96%, positive predictive value of 97% and specificity of 98%). Isotopic imaging detected the abnormal tissue in all patients who had undergone unsuccessful previous surgery. PTH (4 [SD, 1.51] pmol/l) and calcium postoperative serum levels (2.13 [SD, 0.22] mmol/l) showed curation of all patients.Double phase parathyroid scintigraphy with 99mTc-sestamibi is the method of choice to localize abnormal parathyroid glands." @default.
- W1589248370 created "2016-06-24" @default.
- W1589248370 creator A5001655567 @default.
- W1589248370 creator A5002000874 @default.
- W1589248370 creator A5007996931 @default.
- W1589248370 creator A5025951762 @default.
- W1589248370 creator A5031007899 @default.
- W1589248370 creator A5058402432 @default.
- W1589248370 creator A5058755867 @default.
- W1589248370 creator A5059425869 @default.
- W1589248370 creator A5063793634 @default.
- W1589248370 creator A5069925431 @default.
- W1589248370 creator A5079600293 @default.
- W1589248370 date "1999-02-20" @default.
- W1589248370 modified "2023-10-18" @default.
- W1589248370 title "[Isotopic study with double phase 99mTc-sestamibi in the localization of parathyroid gland lesions]." @default.
- W1589248370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10191481" @default.
- W1589248370 hasPublicationYear "1999" @default.
- W1589248370 type Work @default.
- W1589248370 sameAs 1589248370 @default.
- W1589248370 citedByCount "3" @default.
- W1589248370 crossrefType "journal-article" @default.
- W1589248370 hasAuthorship W1589248370A5001655567 @default.
- W1589248370 hasAuthorship W1589248370A5002000874 @default.
- W1589248370 hasAuthorship W1589248370A5007996931 @default.
- W1589248370 hasAuthorship W1589248370A5025951762 @default.
- W1589248370 hasAuthorship W1589248370A5031007899 @default.
- W1589248370 hasAuthorship W1589248370A5058402432 @default.
- W1589248370 hasAuthorship W1589248370A5058755867 @default.
- W1589248370 hasAuthorship W1589248370A5059425869 @default.
- W1589248370 hasAuthorship W1589248370A5063793634 @default.
- W1589248370 hasAuthorship W1589248370A5069925431 @default.
- W1589248370 hasAuthorship W1589248370A5079600293 @default.
- W1589248370 hasConcept C126322002 @default.
- W1589248370 hasConcept C126838900 @default.
- W1589248370 hasConcept C142724271 @default.
- W1589248370 hasConcept C2775945674 @default.
- W1589248370 hasConcept C2776423551 @default.
- W1589248370 hasConcept C2777428134 @default.
- W1589248370 hasConcept C2777919317 @default.
- W1589248370 hasConcept C2778248654 @default.
- W1589248370 hasConcept C2779053571 @default.
- W1589248370 hasConcept C2779902710 @default.
- W1589248370 hasConcept C2780273267 @default.
- W1589248370 hasConcept C2781167329 @default.
- W1589248370 hasConcept C2781208988 @default.
- W1589248370 hasConcept C2910851616 @default.
- W1589248370 hasConcept C2989005 @default.
- W1589248370 hasConcept C519063684 @default.
- W1589248370 hasConcept C71924100 @default.
- W1589248370 hasConceptScore W1589248370C126322002 @default.
- W1589248370 hasConceptScore W1589248370C126838900 @default.
- W1589248370 hasConceptScore W1589248370C142724271 @default.
- W1589248370 hasConceptScore W1589248370C2775945674 @default.
- W1589248370 hasConceptScore W1589248370C2776423551 @default.
- W1589248370 hasConceptScore W1589248370C2777428134 @default.
- W1589248370 hasConceptScore W1589248370C2777919317 @default.
- W1589248370 hasConceptScore W1589248370C2778248654 @default.
- W1589248370 hasConceptScore W1589248370C2779053571 @default.
- W1589248370 hasConceptScore W1589248370C2779902710 @default.
- W1589248370 hasConceptScore W1589248370C2780273267 @default.
- W1589248370 hasConceptScore W1589248370C2781167329 @default.
- W1589248370 hasConceptScore W1589248370C2781208988 @default.
- W1589248370 hasConceptScore W1589248370C2910851616 @default.
- W1589248370 hasConceptScore W1589248370C2989005 @default.
- W1589248370 hasConceptScore W1589248370C519063684 @default.
- W1589248370 hasConceptScore W1589248370C71924100 @default.
- W1589248370 hasIssue "6" @default.
- W1589248370 hasLocation W15892483701 @default.
- W1589248370 hasOpenAccess W1589248370 @default.
- W1589248370 hasPrimaryLocation W15892483701 @default.
- W1589248370 hasRelatedWork W1589248370 @default.
- W1589248370 hasRelatedWork W1859039620 @default.
- W1589248370 hasRelatedWork W2014382080 @default.
- W1589248370 hasRelatedWork W2044176959 @default.
- W1589248370 hasRelatedWork W2076343297 @default.
- W1589248370 hasRelatedWork W2162323286 @default.
- W1589248370 hasRelatedWork W2274036625 @default.
- W1589248370 hasRelatedWork W2333335078 @default.
- W1589248370 hasRelatedWork W2401982586 @default.
- W1589248370 hasRelatedWork W2411883420 @default.
- W1589248370 hasVolume "112" @default.
- W1589248370 isParatext "false" @default.
- W1589248370 isRetracted "false" @default.
- W1589248370 magId "1589248370" @default.
- W1589248370 workType "article" @default.